Trexquant Investment LP

Position in TBPH — Theravance Biopharma, Inc.

CIK 1633445 STAMFORD, CT

Position in TBPH

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,339,874

-$74,513 QoQ

Shares Held

205,784

+12.8% QoQ

Ownership

0.399%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Mar 31, 2026

Trexquant Investment LP holds $455,705,746 across 119 Biotechnology names. TBPH ranks #51 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	483,971	$24,585,726
2	ALNY	Alnylam Pharmaceuticals, Inc.	61,760	$20,434,531
3	ARWR	Arrowhead Pharmaceuticals, Inc.	277,114	$17,375,047
4	EXEL	Exelixis, Inc.	390,818	$16,762,184
5	HRMY	Harmony Biosciences Holdings, Inc.	594,850	$16,661,748
6	IONS	Ionis Pharmaceuticals Inc	213,645	$16,042,603
7	ASND	Ascendis Pharma A/S	65,517	$14,985,703
8	TGTX	Tg Therapeutics, Inc.	311,219	$10,338,695

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,339,874	205,784	+12.8%	Shares	Sole	2026-05-15
2025-12-31	$3,414,387	182,490	+26.3%	Shares	Sole	2026-02-17
2025-09-30	$2,110,181	144,533	-7.9%	Shares	Sole	2025-11-14
2025-06-30	$1,730,937	156,930	-5.1%	Shares	Sole	2025-08-12
2025-03-31	$1,477,236	165,424	+9.5%	Shares	Sole	2025-05-14
2024-12-31	$1,421,691	151,083	+50.7%	Shares	Sole	2025-02-12
2024-09-30	$808,071	100,257	+199.1%	Shares	Sole	2024-11-12
2024-06-30	$284,266	33,522	+79.2%	Shares	Sole	2024-08-13
2022-12-31	$209,870	18,705	-9.8%	Shares	Sole	2023-02-13
2021-12-31	$229,055	20,729	+57.4%	Shares	Sole	2022-02-14
2020-09-30	$194,674	13,167	+18.3%	Shares	Sole	2020-11-06
2020-06-30	$233,534	11,126	—	Shares	Sole	2020-08-07
No filing history on record for this holder in this stock.